Panorchan Kwanpeemai, Davenport Andrew
UCL Centre for Nephrology, Royal Free Hospital, University College London Medical School, London, UK.
UCL Centre for Nephrology, Royal Free Hospital, University College London Medical School, London, UK
Perit Dial Int. 2017 May-Jun;37(3):338-340. doi: 10.3747/pdi.2016.00213.
Renal replacement therapy is designed to treat uremic symptoms and correct hypervolemia. We hypothesized that starting peritoneal dialysis (PD) should reduce overhydration, and we measured body composition and hydration status using bioimpedance in PD patients prior to training and then at the first assessment of peritoneal membrane function. We studied 100 consecutive patients with a planned start to PD, without peritoneal infections or mechanical catheter problems, mean age 54.7 ± 17.1 years, 57% male and 25% diabetic. Extracellular water (ECW) overhydration increased from -0.06 (-1.21 to 0.97) L to 0.96 (0.50 to 3.01) L, < 0.001. Fat mass increased from 22.7 ± 11.1 to 23.7 ± 11.3 kg, = 0.007). The change in ECW/total body water (TBW) was associated with age (β 0.065, < 0.001), increasing comorbidity (β 1.107, = 0.005), faster peritoneal protein transport (β 1.84, < 0.04), and negatively with serum albumin (β -0.208, < 0.001), and residual renal function (β -0.725, = 0.026). Patients who had an increase in ECW/TBW had higher C-reactive protein (CRP) both before starting (16.8 ± 24.1 vs 7.7 ± 18.9 mg/L), and when established on PD (15.0 ± 31.8 vs 4.6 ± 5.1 mg/L), < 0.05. Rather than a reduction in ECW hydration status, overhydration increased after starting PD. This was greater for older more comorbid patients and those with an inflammatory milieu and lower residual renal function. These factors should be considered when deciding upon initial PD prescriptions to limit ECW overhydration before information on peritoneal membrane function becomes available.
肾脏替代疗法旨在治疗尿毒症症状并纠正血容量过多。我们假设开始腹膜透析(PD)应能减轻水过多,并且我们在培训前以及首次评估腹膜功能时,使用生物电阻抗测量了PD患者的身体成分和水合状态。我们研究了100例计划开始进行PD的连续患者,这些患者无腹膜感染或机械导管问题,平均年龄54.7±17.1岁,男性占57%,糖尿病患者占25%。细胞外液(ECW)水过多从-0.06(-1.21至0.97)L增加至0.96(0.50至3.01)L,P<0.001。脂肪量从22.7±11.1增加至23.7±11.3kg,P = 0.007)。ECW/总体水(TBW)的变化与年龄(β0.065,P<0.001)、合并症增加(β1.107,P = 0.005)、腹膜蛋白转运加快(β1.84,P<0.04)呈正相关,与血清白蛋白(β -0.208,P<0.001)和残余肾功能(β -0.725,P = 0.026)呈负相关。ECW/TBW增加的患者在开始透析前(16.8±24.1 vs 7.7±18.9mg/L)和确定进行PD时(15.0±31.8 vs 4.6±5.1mg/L)的C反应蛋白(CRP)均较高,P<0.05。开始PD后,水过多状况非但没有减轻,反而增加了。对于年龄较大、合并症较多以及有炎症环境和残余肾功能较低的患者,这种情况更为明显。在获得腹膜功能信息之前,决定初始PD处方以限制ECW水过多时,应考虑这些因素。